Mark Forman
Equibles does not estimate personal net worth.
About Mark Forman
Passage BIO, Inc. reported in an 8-K filed August 1, 2024 that Mark Forman resigned as Chief Medical Officer, effective August 2, 2024.
“On July 26, 2024, Mark Forman, M.D., Ph.D., notified the Company of his decision to resign from his position as the Company's Chief Medical Officer, effective as of August 2, 2024.”
Affiliation history
-
Passage BIO, Inc. (PASG)
Proxy statement
Start not stated–2024-08-02